Abstract:The conventional formulation of luliconazole (LCZ) faces challenges such as poor solubility and limited skin retention upon application. Therefore, the focus of this research was to develop and characterize mesoporous silica nanoparticles (MSN) that can effectively deliver luliconazole for the treatment of cutaneous candidiasis fungal infection. The MSNs were optimized by central composite design and synthesized using the sol−gel method. Factors such as stirring time and surfactant ratio were varied to investigate their impact on particle size and Polydispersity index (PDI). Subsequently, the MSN surface was functionalized with both amine (positively charged) and phosphonate groups (negatively charged) using 3-aminopropyltriethoxysilane (APTES) and 3trihydroxysilyl propyl methylphosphonate (THMP). The efficacy of the optimized luliconazole−loaded MSNs was evaluated through various comparative studies, including in-vitro and in-vivo antifungal assessments, ex-vivo permeation and skin retention experiments, acute dermal irritation tests, and histopathological analysis. These evaluations were compared with the pure drug and a commercially available formulation. The optimized MSNs exhibited high porosity and spherical particle sizes ranging from 300 to 400 nm. They demonstrated excellent physical and chemical stability, indicating compatibility between the drug and the MSN structure. The successful loading of luliconazole into the nanopores of the MSNs was confirmed through Brunauer Emmett Teller (BET) analysis. The luliconazole−loaded MSN (LCZ−MSN) gel exhibited a controlled release profile, sustaining drug release for up to 24 h. The solubility of the drug was 12 times higher compared to the free form, and the MSNs enhanced skin retention by six−fold compared to the pure drug. In an in-vivo cutaneous candidiasis rat model, the enhanced efficacy of the MSNs was evident, highlighting the potential of this innovative approach for controlled release and solubility enhancement of poorly soluble drugs, with no observed skin irritation. Overall, this research showcases the potential of mesoporous silica nanoparticles as a promising approach for controlled delivery and improved solubility of poorly soluble drugs like luliconazole, thereby addressing the challenges associated with conventional formulations and offering a novel strategy for treating cutaneous candidiasis fungal infection.

Optimization of invasomal gel of miconazole nitrate for the treatment of topical fungal infections

Development of synergistic antifungal in situ gel of miconazole nitrate loaded microemulsion as a novel approach to treat vaginal candidiasis

In Vitro, Ex Vivo, and In Vivo Evaluation of Nanoparticle-Based Topical Formulation Against Candida albicans Infection

Investigating the efficacy of mirtazapine-embedded invasomal gel nanocarriers via I-optimal design for management of atopic dermatitis

Optimizing fluconazole-embedded transfersomal gel for enhanced antifungal activity and compatibility studies

In Silico Guided Nanoformulation Strategy for Circumvention of Candida albicans Biofilm for Effective Therapy of Candidal Vulvovaginitis

Development and Characterization of Econazole Topical Gel

Posaconazole-hemp seed oil loaded nanomicelles for invasive fungal disease

Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approach

Formulation evaluation of ketoconazole microemulsion-loaded hydrogel with nigella oil as a penetration enhancer

In Vivo Evaluation of Miconazole-Nitrate-Loaded Transethosomal Gel Using a Rat Model Infected with Candida albicans

Development and evaluation of nanoemulsion gel loaded with bioactive extract of Cucumis melo var. agrestis: A novel approach for enhanced skin permeability and antifungal activity

Preparation and Characterization of Luliconazole Nanoemulsion Based Hydrogel

Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies

Formulation development and characterization of luliconazole loaded−mesoporous silica nanoparticles (MCM−48) as topical hydrogel for the treatment of cutaneous candidiasis

The Unique Carboxymethyl Fenugreek Gum Gel Loaded Itraconazole Self-Emulsifying Nanovesicles for Topical Onychomycosis Treatment

Augmentation of antifungal activity of fluconazole using a clove oil nanoemulgel formulation optimized by factorial randomized D-optimal design

Microemulgel Delivery of Ciprofloxacin Hydrochloride

DESIGN, FABRICATION, IN VITRO, AND EX-VIVO PERMEATION STUDY OF MICRO-EMULSIFIED HYDROGEL OF FLUCONAZOLE (MHG-FLCZ) USING A CENTRAL COMPOSITE DESIGN (CCD)

Statistical optimization of voriconazole nanoparticles loaded carboxymethyl chitosan-poloxamer based in situ gel for ocular delivery: In vitro, ex vivo, and toxicity assessment

Formulation and Evaluation of Nanoemulgels for the Topical Drug Delivery of Posaconazole